Company Data
Verve Therapeutics Inc.
Ticker
VERV
Current Price
$11.03 -0.27%
Market Cap
$983.2M
Price Target
Refer to Report
Volume
2.4M
52wk Range
$2.8647 - $11.405
Overview
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company’s initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.